scispace - formally typeset
C

Charles A. Dinarello

Researcher at University of Colorado Denver

Publications -  1073
Citations -  152254

Charles A. Dinarello is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Interleukin & Cytokine. The author has an hindex of 190, co-authored 1058 publications receiving 139668 citations. Previous affiliations of Charles A. Dinarello include University of Guadalajara & Pennsylvania State University.

Papers
More filters
Journal ArticleDOI

Increased interleukin 1 beta in human skeletal muscle after exercise.

TL;DR: Results implicate IL-1 beta in the metabolic adaptations of muscle tissue, which occur in response to noninfectious stresses, as well as in the anabolic and catabolic processes that can last for several days.
Journal ArticleDOI

Anti-cytokine therapeutics and infections

TL;DR: There is a growing body of clinical evidence that neutralization of TNF-alpha is associated with an increased risk of opportunistic infections, including mycobacterial diseases, and blockade of IL-1 activity with the IL- 1 receptor antagonist (IL-1Ra) appears, at present, to be relatively safe.
Journal ArticleDOI

Mechanisms of Inhibition of Collagen-Induced Arthritis by Murine IL-18 Binding Protein

TL;DR: The mechanisms of mIL-18BP inhibition of CIA include reductions in cell-mediated and humoral immunity to collagen as well as decreases in production of proinflammatory cytokines in the spleen and joints.
Journal ArticleDOI

Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells

TL;DR: The kit ligand (KL), also termed stem cell factor (SCF), is a recently discovered hematopoietic growth factor that augments response of early progenitor cells to other growth factors and supports proliferation of continuous mast cell lines.
Journal ArticleDOI

Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis.

TL;DR: In the presence of plasma, IL-1-inducing factors pass into the blood compartment of a dialysis system challenged with bacterial pyrogen; and in vitro MNC production ofIL-1 is enhanced in the absence of plasma.